Ethnic differences in hormone replacement prescribing patterns
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
OBJECTIVE: To determine whether prescription patterns of hormone replacement therapy (HRT) differ in African-American, Asian, Latina, Soviet immigrant, and white women.
DESIGN: Retrospective review of computerized medical records.
SETTING: The general internal medicine, family medicine, and gynecology practices of an academic medical center.
PATIENTS: Women aged 50 years or older with at least one outpatient visit from January 1, 1992, to November 30, 1995.
MEASUREMENTS AND MAIN RESULTS: Use of HRT was defined as documentation of systemic estrogen use. The main predictor variable was self-identified ethnicity. Age, diagnosis (coronary heart disease, hypertension, diabetes, osteoporosis, or breast cancer), and median income were included in the analysis. Of the 8,968 women (mean age, 65.4 years) included, 50% were white, 20% Asian, 15% African American, 9% Latina, and 6% Soviet immigrants. Whites (33%) were significantly more likely to be prescribed HRT than Asians (21%), African Americans (25%), Latinas (23%), or Soviet immigrants (6.6%), p<0.01 for each. Multivariate analysis, comparing ethnic groups and controlling for confounding variables, showed that Asians (odds ratio [OR] 0.56; 95% confidence interval [CI] 0.49, 0.64), African Americans (OR 0.70; 95% CI 0.60, 0.81), Latinas (OR 0.70; 95% CI 0.58, 0.84), and Soviet immigrants (OR 0.14; 95% CI 0.10, 0.20) were each less likely to be prescribed HRT than were white women. Although women with osteoporosis were more likely to receive HRT (OR 2.28; 95% CI 1.71, 2.99), those with coronary heart disease were not (OR 0.88; 95% CI 0.68, 1.09).
CONCLUSIONS: Physicians at this medical center were more likely to prescribe HRT for white women and women with osteoporosis. Further study is needed to address whether these differences in HRT prescribing result in different health outcomes.
- Kiel, DP, Felson, DT, Anderson, JJ, Wilson, PW, Moskowitz, MA (1987) Hip fracture and the use of estrogens in postmenopausal women: the Framingham study. N Engl J Med 317: pp. 1169-74 CrossRef
- Johnson, RE, Specht, EE (1981) The risk of hip fracture in postmenopausal females with or without estrogen drug exposure. Am J Public Health 71: pp. 138-44
- Paganini-Hill, A, Ross, RK, Gerkins, VR, Henderson, BE, Arthur, M, Mack, TM (1981) Menopausal estrogen therapy and hip fractures. Ann Intern Med 95: pp. 28-31
- Ettinger, B, Genant, HK, Cann, CE (1985) Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102: pp. 319-24
- Naessen, T, Persson, I, Adami, HO, Bergstrom, R, Bergkvist, L (1990) Hormone replacement therapy and the risk for first hip fracture: a prospective, population-based cohort study. Ann Intern Med 113: pp. 95-103
- Grady, D, Rubin, SM, Petitti, DB (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: pp. 1016-37
- Cummings, SR, Nevitt, MC, Browner, WS (1995) Risk factors for hip fracture in white women: Study of Osteoporotic Fractures Research Group. N Engl J Med 332: pp. 767-73 CrossRef
- Sullivan, JM, Zwaag, R, Hughes, JP (1990) Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 150: pp. 2557-62 CrossRef
- Stampfer, MJ, Colditz, GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: pp. 47-63 CrossRef
- Criqui, MH, Suarez, L, Barrett-Connor, E, McPhillips, J, Wingard, DL, Garland, C (1988) Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am J Epidemiol 128: pp. 606-14
- Ettinger, B, Friedman, GD, Bush, T, Quesenberry, CP (1996) Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87: pp. 6-12 CrossRef
- Colditz, GA, Egan, KM, Stampfer, MJ (1993) Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 168: pp. 1473-80
- Colditz, GA, Hankinson, SE, Hunter, DJ (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: pp. 1589-93 CrossRef
- Stanford, JL, Weiss, NS, Voigt, LF, Daling, JR, Habel, LA, Rosing, MA (1995) Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 274: pp. 137-42 CrossRef
- Grady, D, Gebretsadik, T, Kerlikowske, K, Ernster, V, Petitti, D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85: pp. 304-13 CrossRef
- Hulley, S, Grady, D, Bush, T (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: pp. 605-13 CrossRef
- Hemminki, E, Kennedy, DL, Baum, C, McKinlay, SM (1988) Prescribing of noncontraceptive estrogens and progestins in the United States, 1974–86. Am J Public Health 78: pp. 1479-81
- Cauley, JA, Cummings, SR, Black, DM, Mascioli, SR, Seeley, DG (1990) Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163: pp. 1438-44
- Griffiths, F, Convery, B (1995) Women’s use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract 45: pp. 355-8
- Barrett-Connor, E, Wingard, DL, Criqui, MH (1989) Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. JAMA 261: pp. 2095-100 CrossRef
- Campbell-Brown, M, McEwan, HP (1992) Scottish gynaecologists: their views on hormone replacement therapy. Health Bull (Edinb) 50: pp. 248-51
- Ponte, CD, Swinker, ML, Madhavan, S (1989) Estrogen replacement therapy: a pilot survey of primary care physicians in West Virginia. DICP-Ann Pharmacother 23: pp. 977-9
- Pasley, BH, Standfast, SJ, Katz, SH (1984) Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981. Public Health Rep 99: pp. 424-9
- Anderson, E, Hamburger, S, Liu, JH, Rebar, RW (1987) Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 156: pp. 428-33
- Ferguson, KJ, Hoegh, C, Johnson, S (1989) Estrogen replacement therapy: a survey of women’s knowledge and attitudes. Arch Intern Med 149: pp. 133-6 CrossRef
- Ross, RK, Paganini-Hill, A, Roy, S, Chao, A, Henderson, BE (1988) Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health. Am J Public Health 78: pp. 516-9
- Schmitt, N, Gogate, J, Rothert, M (1991) Capturing and clustering women’s judgment policies: the case of hormonal therapy for menopause. J Gerontol 46: pp. 92-101
- Pilote, L, Hlatky, MA (1995) Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J 129: pp. 1237-8 CrossRef
- Groeneveld, FP, Bareman, FP, Barentsen, R, Dokter, HJ, Drogendijk, AC, Hoes, AW (1993) Relationships between attitude towards menopause, well-being and medical attention among women aged 45–60 years. Maturitas 17: pp. 77-88 CrossRef
- Stafford, RS, Saglam, D, Causino, N, Blumenthal, D (1996) Low rates of hormone replacement therapy by U.S. physicians. J Gen Intern Med 11: pp. 89-89
- Keating, NL, Cleary, PD, Rossi, AS, Zaslavsky, AM, Ayanian, JZ (1999) Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 130: pp. 545-53
- Nabulsi, AA, Folsom, AR, White, A (1993) Association of hormonereplacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communicties Study Investigators. N Engl J Med 328: pp. 1069-75 CrossRef
- Egeland, GM, Matthews, KA, Kuller, LH, Kelsey, SF (1988) Characteristics of noncontraceptive hormone users. Prev Med 17: pp. 403-11 CrossRef
- Bartman, BA, Moy, E (1998) Racial differences in estrogen use among middle-aged and older women. Women’s Health Issues 8: pp. 32-44 CrossRef
- Bachhuber, TL, Baybrook, SL, Philbrick, JT (1996) Hormone replacement therapy: knowledge, attitudes and use among low income women. J Gen Intern Med 11: pp. 139-139
- Pham, KC, Freeman, EW, Grisso, TA (1996) Ovarian aging and hormone replacement therapy: attitudes of Afro-american and Caucasian women. J Gen Intern Med 11: pp. 136-136
- Jahnige, K, Fiebach, N (1997) Postmenopausal estrogen use among African American and white patients at an urban clinic. J Women’s Health 6: pp. 93-101 CrossRef
- McNagny, SE, Wenger, NK, Frank, E (1997) Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Ann Intern Med 127: pp. 1093-6
- Holmes, MM, Rovner, DR, Rothert, ML (1987) Women’s and physicians’ utilities for health outcomes in estrogen replacement therapy. J Gen Intern Med 2: pp. 178-82 CrossRef
- Garton, M, Reid, D, Rennie, E (1995) The climacteric, osteoporosis and hormone replacement; views of women aged 45–49. Maturitas 21: pp. 7-15 CrossRef
- Griffiths, F (1995) Women’s health concerns. Is the promotion of hormone replacement therapy for prevention important to women?. Fam Pract 12: pp. 54-9 CrossRef
- Lip, G, Beevers, M, Churchill, D, Beevers, DG (1995) Do clinicians prescribe HRT for hypertensive postmenopausal women?. Br J Clin Pract 49: pp. 61-4
- Carlisle, DM, Leake, BD, Shapiro, MF (1995) Racial and ethnic differences in the use of invasive cardiac procedures among cardiac patients in Los Angeles County, 1986 through 1988. Am J Public Health 85: pp. 352-6
- Selby, JV, Fireman, BH, Swain, BE (1996) Effect of a copayment on use of the emergency department in a health maintenance organization. N Engl J Med 334: pp. 635-41 CrossRef
- Norman, SG, Studd, JW (1994) A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 101: pp. 879-87
- Sinclair, HK, Bond, CM, Taylor, RJ (1993) Hormone replacement therapy: a study of women’s knowledge and attitudes. Br J Gen Pract 43: pp. 365-70
- Liao, Y, Cooper, RS (1995) Continued adverse trends in coronary heart disease mortality among blacks, 1980–91. Public Health Rep 110: pp. 572-9
- Baird, DD, Tyroler, HA, Heiss, G, Chambless, LE, Hames, CG (1985) Menopausal change in serum cholesterol: black/white differences in Evans County, Georgia. Am J Epidemiol 122: pp. 982-93
- Demirovic, J, Sprafka, JM, Folsom, AR, Laitinen, D, Blackburn, H (1992) Menopause and serum cholesterol: differences between blacks and whites. The Minnesota Heart Survey. Am J Epidemiol 136: pp. 155-64
- Nicholson, WK, Brown, AF, Gathe, J, Grumbach, K, Washington, AE, Pérez-Stable, EJ (1999) Hormone replacement therapy for African-American women: missed opportunities for effective intervention. Menopause 6: pp. 147-55 CrossRef
- Nabulsi, AA, Folsom, AR, White, A (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328: pp. 1069-75 CrossRef
- Cronkright, PJ, DeHaven, K, Kraev, IA (1993) Issues in the provision of health care to Soviet emigrants. Arch Fam Med 2: pp. 425-8 CrossRef
- Haywood, LJ, Ell, K, Guman, M, Norris, S, Blumfield, D, Sobel, E (1993) Chest pain admissions: characteristics of black, Latino, and white patients in low- and mid-socioeconomic strata. J Natl Med Assoc 85: pp. 749-57
- Stroup-Benham, CA, Treviño, FM (1991) Reproductive characteristics of Mexican-American, mainland Puerto Rican, and Cuban-American women: data from the Hispanic Health and Nutrition Examination Survey. JAMA 265: pp. 222-6 CrossRef
- Daley, J (1999) Medical uncertainty and practice variation get personal: What should I do about hormone replacement therapy?. Ann Intern Med 130: pp. 602-3
- Ethnic differences in hormone replacement prescribing patterns
Journal of General Internal Medicine
Volume 14, Issue 11 , pp 663-669
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- hormone replacement therapy
- postmenopausal women
- physician prescribing
- Industry Sectors
- Author Affiliations
- 1. Received from the Medical Effectiveness Research Center for Diverse Populations, University of California, San Francisco, Calif.
- 2. the Division of General Internal Medicine in the Department of Medicine, University of California, San Francisco, Calif.
- 3. the Center for Aging in Diverse Communities, University of California, San Francisco, Calif.
- 5. the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Calif.